We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Eli Lilly’s Olumiant Reduces COVID-19 Mortality
Eli Lilly’s rheumatoid arthritis treatment Olumiant (baricitinib) reduced mortality in COVID-19 patients by 71 percent in a small clinical trial led by Sweden’s Karolinska Institutet.